Publications by authors named "Robin Haimbach"

Claim this Profile
P
PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy.
Xiaoyan Zhou, Eric S Muise, Robin Haimbach, Iyassu K Sebhat, Yonghua Zhu

J Pharmacol Exp Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.
Xiaoyan Zhou, Ji Zhang, Robin Haimbach, Wei Zhu, Rosemary Mayer-Ezell

Pharmacol Res Perspect· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores.
Shuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, Yang Yu, Zhicai Wu, Robin E Haimbach

Bioorg Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).
Gregory Pancari, Hongxia Fan, Sharon Smith, Amita Joshi, Robin Haimbach

Front Cell Infect Microbiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Jeffrey J Legos, Stephen C Lenhard, Robin E Haimbach, Thomas R Schaeffer, Ross G Bentley

Exp Neurol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging.
Stephen C Lenhard, Robin E Haimbach, Anthony C Sulpizio, David P Brooks, Jeffrey D Bray

Fertil Steril· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
Haisong Ju, David J Behm, Sandyha Nerurkar, Marianne E Eybye, Robin E Haimbach

J Pharmacol Exp Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.
Beat M Jucker, Thomas R Schaeffer, Robin E Haimbach, Matthew E Mayer, Derek H Ohlstein

Metabolism· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
Beat M Jucker, Thomas R Schaeffer, Robin E Haimbach, Thomas S McIntosh, Daniel Chun

Diabetes· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis